We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the subtle early symptoms and medical signs of multiple myeloma, a blood cancer affecting plasma cells. Understand the importance of early detection for better outcomes.

Multiple myeloma is a type of blood cancer that affects plasma cells, a type of white blood cell found in the bone marrow. These cells are a crucial part of the immune system, producing antibodies that help fight infections. In multiple myeloma, these plasma cells grow uncontrollably, crowding out healthy blood cells and leading to various health problems. While it is more common in individuals over 65, it can affect younger people too. It's essential to be aware of the early signs, as they can be subtle and easily mistaken for other common ailments. Early detection and diagnosis are key to better treatment outcomes and managing the condition effectively.
Multiple myeloma originates in the bone marrow, the soft, spongy tissue inside bones where blood cells are made. Specifically, it arises from plasma cells, which normally produce antibodies. When these cells become cancerous (myeloma cells), they multiply abnormally. This overgrowth can lead to a buildup of abnormal protein in the blood and urine, and it can damage bones, compromise the immune system, and affect kidney function.
One of the challenges with multiple myeloma is that its early stages are often asymptomatic, meaning there are no noticeable symptoms. When symptoms do appear, they can be vague and easily dismissed. It's crucial to pay attention to your body and consult a doctor if you experience persistent or unusual symptoms. Some potential early signs include:
Sometimes, changes related to multiple myeloma can be detected in routine blood or urine tests even before any symptoms are noticeable. These medical signs include:
Because the early symptoms can be vague, they are often mistaken for other, more common conditions. These can include:
It's also important to note that other blood disorders, like Waldenstrom macroglobulinemia or light-chain amyloidosis, can share some similarities with multiple myeloma.
Diagnosing multiple myeloma typically involves a combination of:
Treatment for multiple myeloma depends on the stage of the disease, the patient's overall health, and the presence of symptoms. Options may include:
It is crucial to consult a healthcare professional if you experience any of the persistent or concerning symptoms mentioned above, especially if you have risk factors for multiple myeloma. These risk factors include being over 65, being of Black ethnicity, being male, or having a history of certain blood disorders like MGUS (Monoclonal Gammopathy of Undetermined Significance). Don't ignore persistent bone pain, unexplained fatigue, frequent infections, or changes in urination habits. Early diagnosis can significantly improve treatment effectiveness and prognosis.
Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026